Acquired Company

BioNTech acquired CureVac N.V. on December 18, 2025 in an all-stock transaction valued at approximately $1.25 billion, with CureVac shareholders receiving about $5.46 in BioNTech ADSs per CureVac share.

CureVac NV (CVAC) is an innovative clinical-stage biopharmaceutical company based in Tübingen, Germany, focused on the development of cutting-edge messenger RNA (mRNA) therapies and vaccines. With a diverse pipeline targeting critical unmet medical needs in oncology and infectious diseases, CureVac aims to leverage its proprietary mRNA technology to deliver transformative healthcare solutions. The company is well-positioned for growth through strategic collaborations and a commitment to scientific excellence, making it a key player in the rapidly advancing mRNA sector. Show more

Location: FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, GERMANY, 72076, Tübingen, 72076, USA | Website: https://www.curevac.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

1.049B

52 Wk Range

$2.48 - $5.72

Previous Close

$4.66

Open

$4.66

Volume

N/A

Day Range

$4.66 - $4.66

Enterprise Value

599.3M

Cash

416.1M

Avg Qtr Burn

N/A

Insider Ownership

0.10%

Institutional Own.

10.43%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Flu SV Vaccine Details Seasonal influenza, Viral infection	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Avian Infuenza Vaccine Details Influenza, Viral infection	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CVGBM Cancer Vaccine Details Cancer, Glioblastoma	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CVHNLC Details Squamous non-small cell lung cancer	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
UTI Prophylactic Vaccine Details UTI Prophylactic Vaccine	IND Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.